ConductScience.org, home

Paper39155331

In silico and experimental potentials of 6-shogaol and meglumine antimoniate on Leishmania major: multiple synergistic combinations through modulation of biological properties.

Shahsavari S and 5 others. Immunol Res, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. In silico and experimental potentials of 6-shogaol and meglumine antimoniate on Leishmania major: multiple synergistic combinations through modulation of biological properties. Papers, record 39155331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39155331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In silico and experimental potentials of 6-shogaol and meglumine antimoniate on Leishmania major: multiple synergistic combinations through modulation of biological properties.
PubMed
Journal
Immunol Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.73, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shahsavari SSaeid
2Sharifi IIraj
3Salarkia EEhsan
4Keyhani AAlireza
5Sharifi FFatemeh
6Babaei ZZahra

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Meglumine AntimoniateMajor topic
Nitric OxideMajor topic
Nitric Oxide Synthase Type IIMajor topic
Leishmania majorMajor topic
Antiprotozoal AgentsMajor topic
CatecholsMajor topic
Drug SynergismMajor topic
Animals
Mice
Macrophages
Apoptosis
Antioxidants
Molecular Docking Simulation
Leishmaniasis, Cutaneous
RAW 264.7 Cells
Humans
Meglumine
Computer Simulation
Organometallic Compounds

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
99001204Kerman University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135106852A systematic review and meta-analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease.Phytother Res2022https://conductscience.org/library/papers/35106852PubMed
226829519In Vitro and In Vivo Antileishmanial Activities of Pistacia vera Essential Oil.Planta Med2016https://conductscience.org/library/papers/26829519PubMed
334890999Exploring the paradox of defense between host and Leishmania parasite.Int Immunopharmacol2022https://conductscience.org/library/papers/34890999PubMed
434648927The effects of medicinal herbs and marine natural products on wound healing of cutaneous leishmaniasis: A systematic review.Microb Pathog2021https://conductscience.org/library/papers/34648927PubMed
531736746Isobologram Analysis: A Comprehensive Review of Methodology and Current Research.Front Pharmacol2019https://conductscience.org/library/papers/31736746PubMed
616778319Current scenario of drug development for leishmaniasis.Indian J Med Res2006https://conductscience.org/library/papers/16778319PubMed
734648629ASSESSMENT OF THE OXIDATIVE AND NITROSATIVE STRESS IN THE SERUM OF SAUDI PATIENTS WITH CUTANEOUS LEISHMANIASIS BEFORE AND AFTER TREATMENT.J Parasitol2021https://conductscience.org/library/papers/34648629PubMed
834203813Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34203813PubMed
917761485Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes.J Med Microbiol2007https://conductscience.org/library/papers/17761485PubMed
1034688150In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects.Int Immunopharmacol2021https://conductscience.org/library/papers/34688150PubMed
1133957562Host immune response against leishmaniasis and parasite persistence strategies: A review and assessment of recent research.Biomed Pharmacother2021https://conductscience.org/library/papers/33957562PubMed
1235147170Orally consumed ginger and human health: an umbrella review.Am J Clin Nutr2022https://conductscience.org/library/papers/35147170PubMed
1335472413In silico and in vitro antileishmanial effects of gamma-terpinene: Multifunctional modes of action.Chem Biol Interact2022https://conductscience.org/library/papers/35472413PubMed
1431540192Key Topics in Molecular Docking for Drug Design.Int J Mol Sci2019https://conductscience.org/library/papers/31540192PubMed
1530771740Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.Int Immunopharmacol2019https://conductscience.org/library/papers/30771740PubMed
1632590317The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.Int Immunopharmacol2020https://conductscience.org/library/papers/32590317PubMed
1732931505The effects of solid-state fermentation on the content, composition and in vitro antioxidant activity of flavonoids from dandelion.PLoS One2020https://conductscience.org/library/papers/32931505PubMed
1837682934In silico and in vitro potentials of crocin and amphotericin B on Leishmania major: Multiple synergistic mechanisms of actions.PLoS One2023https://conductscience.org/library/papers/37682934PubMed
1933765083The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism.PLoS Pathog2021https://conductscience.org/library/papers/33765083PubMed
2034664543Vaccines against leishmaniasis: using controlled human infection models to accelerate development.Expert Rev Vaccines2021https://conductscience.org/library/papers/34664543PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42643551Effectiveness of harmaline along with meglumine antimoniate on Leishmania major.Vet Res Forum2026https://conductscience.org/library/papers/42643551PubMed
40589914An inclusive assessment of apoptosis mechanisms in Leishmania species: A narrative literature review.Curr Res Parasitol Vector Borne Dis2025https://conductscience.org/library/papers/40589914PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39155331

GET https://conductscience.org/api/papers/v1/39155331/references?page=2